• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of advisory committee members and temporary voting members granted conflict of interest waivers during the quarter

Dictionary: When CBER determines that an advisory committee member and voting member has a financial conflict of interest, the agency may grant a waiver that allows the member to participate in an advisory committee meeting if certain criteria and policies are met. In general, CBER may grant a waiver if the member's expertise is considered essential to the committee’s discussions and recommendations. CBER must also take into consideration a cap on the number of waivers that can be granted each year. CBER searches for experts who have the necessary expertise without conflicts of interest; yet, in some cases, many of the top authorities in specialized scientific fields may have a conflict of interest. When CBER grants a waiver, the financial interests associated with the waiver are posted on CBER’s website along with the reasons for granting the waiver.

Information is current as of March 31, 2014

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
October – December 2012100
January – March 2013100
April – June 2013100
July – September 2013100

FY 2013 Total: 0%

Number of CBER advisory committee members and temporary voting members granted a conflict of interest waiver this quarter.

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
October – December 2012N/A0
January – March 2013N/A0
April – June 2013N/A0
July – September 2013N/A0

FY 2013 Total: 0

Number of CBER advisory committee members and temporary voting members attending meetings this quarter.

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
October – December 2012N/A47
January – March 2013N/A60
April – June 2013N/A20
July – September 2013N/A15

FY 2013 Total: 142

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.